Paper · 28972001
Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H and 17 others. Circulation, 2017. Cited by 219 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis. Papers, record 28972001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28972001
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heterogeneous-Nuclear Ribonucleoproteins | Major topic |
| Hypertension, Pulmonary | Major topic |
| MicroRNAs | Major topic |
| Polypyrimidine Tract-Binding Protein | Major topic |
| Pyruvate Kinase | Major topic |
| Alternative Splicing | |
| Animals | |
| Antagomirs | |
| Cattle | |
| Cell Proliferation | |
| Endothelium, Vascular | |
| Fibroblasts | |
| Glycolysis | |
| Histone Deacetylase Inhibitors | |
| Humans | |
| Interleukin-1beta | |
| Macrophages | |
| Mice | |
| Mice, Inbred C57BL | |
| Naphthoquinones | |
| Protein Isoforms | |
| RNA Interference |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA058187 | NCI NIH HHS | United States | P50CA058187 | PubMed | NIH RePORTER |
| P30 DK048520 | NIDDK NIH HHS | United States | P30DK048520 | PubMed and NIH | NIH RePORTER |
| T32 HL007171 | NHLBI NIH HHS | United States | T32HL007171 | PubMed and NIH | NIH RePORTER |
| FS/13/19/29931 | British Heart Foundation | United Kingdom | PubMed | PubMed | |
| RG/13/4/30107 | British Heart Foundation | United Kingdom | PubMed | PubMed | |
| P01 HL014985 | NHLBI NIH HHS | United States | P01HL014985 | PubMed and NIH | NIH RePORTER |
| R01 HL114887 | NHLBI NIH HHS | United States | R01HL114887 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29,255,124 | Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension. | https://conductscience.org/library/papers/29255124 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,562,971 | Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1. | Circulation | 2016 | https://conductscience.org/library/papers/27562971 | PubMed |
| 2 | 26,277,545 | Pyruvate kinase: Function, regulation and role in cancer. | Semin Cell Dev Biol | 2015 | https://conductscience.org/library/papers/26277545 | PubMed |
| 3 | 15,739,122 | Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells. | Basic Res Cardiol | 2005 | https://conductscience.org/library/papers/15739122 | PubMed |
| 5 | 23,900,048 | Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. | Circulation | 2013 | https://conductscience.org/library/papers/23900048 | PubMed |
| 6 | 27,856,534 | PKM2, cancer metabolism, and the road ahead. | EMBO Rep | 2016 | https://conductscience.org/library/papers/27856534 | PubMed |
| 7 | 22,792,411 | Regulation of Aerobic Glycolysis by microRNAs in Cancer. | Mol Cell Pharmacol | 2011 | https://conductscience.org/library/papers/22792411 | PubMed |
| 8 | 22,922,757 | Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. | Nat Chem Biol | 2012 | https://conductscience.org/library/papers/22922757 | PubMed |
| 9 | 24,382,387 | New and emerging HDAC inhibitors for cancer treatment. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24382387 | PubMed |
| 10 | 23,617,881 | Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect. | Eur J Clin Invest | 2013 | https://conductscience.org/library/papers/23617881 | PubMed |
| 11 | 26,699,943 | Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension. | Am J Respir Cell Mol Biol | 2016 | https://conductscience.org/library/papers/26699943 | PubMed |
1 to 10 of 49
See all 49 referencesCited by161
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 219 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,893,628 | Phasic metabolic remodeling coordinates cardiac myofibroblast differentiation and function. | Redox Biol | 2026 | https://conductscience.org/library/papers/42893628 | PubMed |
| 42,733,743 | Heterogeneous nuclear ribonucleoprotein A1 as a candidate associated with pulmonary vascular remodeling in pulmonary arterial hypertension. | J Mol Cell Cardiol Plus | 2026 | https://conductscience.org/library/papers/42733743 | PubMed |
| 42,681,428 | High-Throughput Metabolomics in Transfusion Medicine. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42681428 | PubMed |
| 42,559,126 | Recent advances in targeting cyanine dyes: hierarchical targeting mechanisms and theranostic integration for multi-disease precision therapy. | Theranostics | 2026 | https://conductscience.org/library/papers/42559126 | PubMed |
| 42,171,611 | Hemodynamic and metabolomic responses to infusion of GLP-1 agonist exenatide in pulmonary arterial hypertension. | JCI Insight | 2026 | https://conductscience.org/library/papers/42171611 | PubMed |
| 42,148,308 | PKM2 mediates the glycolytic response to matrix stiffness in lung fibroblasts. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42148308 | PubMed |
| 42,047,020 | Dynamin 2 Regulates Mitochondrial Mitotic Fission in Pulmonary Hypertension. | Circ Res | 2026 | https://conductscience.org/library/papers/42047020 | PubMed |
| 41,881,976 | Dimeric PKM2 in chondrocytes impairs mitochondrial homeostasis in osteoarthritis. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41881976 | PubMed |
| 41,526,595 | Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment. | Geroscience | 2026 | https://conductscience.org/library/papers/41526595 | PubMed |
| 41,393,963 | A Lifelong Journey in the Field of the Pulmonary Circulation: Perspectives Through the Lens of the Cardiovascular Pulmonary Research Laboratory. | Pulm Circ | 2025 | https://conductscience.org/library/papers/41393963 | PubMed |
1 to 10 of 161
See all 161 cited byGenes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BMPR2 | 659 | PubTator's text mining | https://conductscience.org/library/genes/659 | NCBI Gene |
| HNRNPA1 | 3,178 | PubTator's text mining | https://conductscience.org/library/genes/3178 | NCBI Gene |
| HNRNPA2B1 | 3,181 | PubTator's text mining | https://conductscience.org/library/genes/3181 | NCBI Gene |
| HNRNPC | 3,183 | PubTator's text mining | https://conductscience.org/library/genes/3183 | NCBI Gene |
| IL1B | 3,553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3,569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MPC1 | 51,660 | PubTator's text mining | https://conductscience.org/library/genes/51660 | NCBI Gene |
| MPC2 | 25,874 | PubTator's text mining | https://conductscience.org/library/genes/25874 | NCBI Gene |
| PDK1 | 5,163 | PubTator's text mining | https://conductscience.org/library/genes/5163 | NCBI Gene |
| PDP1 | 54,704 | PubTator's text mining | https://conductscience.org/library/genes/54704 | NCBI Gene |
1 to 10 of 16
See all 16 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28972001
GET https://conductscience.org/api/papers/v1/28972001/references?page=2